Nadroparin Versus TIPS in Cirrhotic Patients With Refractory Asymptomatic PVT
Conditions: Portal Vein Thrombosis Interventions: Procedure: TIPS; Drug: Nadroparin Sponsors: Shanghai Zhongshan Hospital; Shanghai 6th People ' s Hospital; Shanghai Shuguang Hospital; Tongji Hospital affiliated to Tongji University; People ' s hospital affiliated to Wuhan University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2024 Category: Research Source Type: clinical trials

Effectiveness of Atorvastatin in Preventing Cerebrovascular Events After Flow Diverter Implantation
Conditions: Efficacy Endpoint: no New Cerebrovascular Adverse Events Within 1 Year; Safety Endpoint: no New Moderate or Serious Adverse Events Within 1 Year; All-cause Mortality Events (Within 1 Year); Incident Ischemic Stroke Events (Within 1 Year); New Hemorrhagic Stroke Events (Within 1 Year); New Stent Thrombosis Events (Within 1 Year); New Symptomatic Stenosis Events (Within 1 Year); Occurrence of In-stent Stenosis 12th ±1 Month Annual Angiographic Follow-up; Degree of In-stent Stenosis (as Measured by WASID Method) at the 12th ±1 Month Annual Angiographic Follow-up; Target Aneurysm Embolization Rate at 12±1 Month ...
Source: ClinicalTrials.gov - March 13, 2024 Category: Research Source Type: clinical trials

Risk Factors of Venous Thromboembolism After Colorectal Cancer Surgery
Conditions: Colorectal Cancer; Venous Thromboembolism Sponsors: Pirogov Russian National Research Medical University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 8, 2024 Category: Research Source Type: clinical trials

5E Program for Preventing Venous Thromboembolism in Patients With Spinal Cord Disorders
Conditions: Venous Thromboembolism; Spinal Cord Diseases; Spinal Cord Injuries; Nurse ' s Role Interventions: Behavioral: 5E program Sponsors: Khon Kaen University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 8, 2024 Category: Research Source Type: clinical trials

Characterization of Exosomes Platelets-released
Conditions: Platelet Thrombus Sponsors: Centro Cardiologico Monzino; Fondazione IRCCS Ca ' Granda, Ospedale Maggiore Policlinico Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2024 Category: Research Source Type: clinical trials

A Trial to Learn How Well REGN9933 and REGN7508 Work for Preventing Blood Clots, and How Safe They Are, in Adults Who Have a Peripherally Inserted Central Catheter (PICC)
Conditions: Venous Thromboembolism Interventions: Drug: REGN9933; Drug: REGN7508; Drug: Placebo Sponsors: Regeneron Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2024 Category: Research Source Type: clinical trials

Acute and Subacute Iliofemoral and/or Caval Deep Vein Thrombosis: Evaluation of Mechanical Thrombectomy Systems in a Monocentric, Observational Retrospective and Prospective Study
Conditions: Thrombosis, Venous Interventions: Other: mechanical thrombectomy of caval and iliofemoral veins Sponsors: IRCCS San Raffaele Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2024 Category: Research Source Type: clinical trials

Aspin: neurosurgical aspirin intervention prognostic study — perioperative continuation versus discontinuation of aspirin in lumbar spinal surgery, a randomized controlled, noninferiority trial
AbstractRationaleAspirin is typically discontinued in cranial and spinal surgery because of the increased risk of hemorrhagic complications, but comes together with the risk of resulting in an increase of cardiac and neurologic thrombotic perioperative events.ObjectiveThe aim of this study is to investigate the non-inferiority of perioperative continuation of aspirin patients undergoing low complex lumbar spinal surgery, compared with the current policy of perioperative discontinuation of aspirin.Study designA randomized controlled trial with two parallel groups of 277 cases (554 in total).Study populationPatients undergoi...
Source: Trials - February 29, 2024 Category: Research Source Type: clinical trials

Development and Validation of a Risk Prediction Model for Venous Thromboembolism in Gynecological Cancer Patients Undergoing Systemic Antineoplastic Treatment: The Gynecological Cancer Associated Thrombosis (GynCAT) Study
Conditions: Cancer-associated Thrombosis; Venous Thromboembolism; Gynecologic Cancer; Ovarian Cancer; Cervix Cancer; Endometrial Cancer; Vaginal Cancer Interventions: Drug: Anticoagulant Sponsors: Fondazione Policlinico Universitario Agostino Gemelli IRCCS; Fondazione Umberto Veronesi Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials

An Observational Study to Learn More About How Safe Treatment With Rivaroxaban is in Children in Japan With Venous Thromboembolism
Conditions: Venous Thromboembolism Interventions: Drug: Rivaroxaban granules for oral suspension; Drug: Warfarin Sponsors: Bayer; Janssen Pharmaceutical Companies (formerly Johnson& Johnson Pharmaceutical Research& Development L.L.C.) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2024 Category: Research Source Type: clinical trials

Clinical Deterioration in Cerebral Venous Thrombosis: A Predictive Study
Conditions: Cerebral Venous Thrombosis Sponsors: Beijing Tiantan Hospital; Beijing Chao Yang Hospital; Beijing Friendship Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 19, 2024 Category: Research Source Type: clinical trials

Evaluation of Safety and Efficacy of Anticoagulation Treatment in Patients With Splanchnic Vein Thrombosis: SAPIENT Study
Conditions: Splanchnic Vein Thrombosis Sponsors: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 16, 2024 Category: Research Source Type: clinical trials

Application of IPC During Surgery to Prevent Venous Thrombosis in Gastrointestinal Surgery Patients.
Conditions: Gastrointestinal Neoplasms; Stomach Neoplasms; Intestinal Neoplasms Interventions: Device: Intermittent Pneumatic Compression Devices Sponsors: Feng Tian Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 15, 2024 Category: Research Source Type: clinical trials

Venous Thrombo-Embolism Imaging Database (VTE-ID)
Conditions: Venous Thromboembolism; Deep Vein Thrombosis; Pulmonary Embolism Sponsors: University Hospital, Brest Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 14, 2024 Category: Research Source Type: clinical trials

The Role of Platelet TLRs in Platelet Activation During VTE
Conditions: Venous Thromboembolism VTE Sequelae, Immunothrombosis, Platelets, Inflammatory Receptors Interventions: Biological: blood sample; Biological: blood sample Sponsors: Centre Hospitalier Universitaire de Saint Etienne Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 13, 2024 Category: Research Source Type: clinical trials